Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Chinese Patent Office
McKinsey
UBS
Cipla
US Army
Covington
US Department of Justice

Generated: February 19, 2019

DrugPatentWatch Database Preview

Litigation Details for TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2010)

« Back to Dashboard

TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2010)

Docket ➤ Sign Up Date Filed 2010-04-05
Court District Court, D. New Jersey Date Terminated 2014-10-16
Cause 35:271 Patent Infringement Assigned To Joel A. Pisano
Jury Demand None Referred To Tonianne J. Bongiovanni
Parties CADILA HEALTHCARE LIMITED; ETHYPHARM, S.A.; TAKEDA PHARMACEUTICAL COMPANY LIMITED; TAKEDA PHARMACEUTICALS AMERICA, INC.; TAKEDA PHARMACEUTICALS LLC; TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.; ZYDUS PHARMACEUTICALS (USA) INC.
Patents 5,464,632; 6,328,994; 7,399,485; 7,431,942; 7,875,292
Attorneys CARISSA L. RODRIGUE; DILLON KIM; ELINA SLAVIN; JOHN EDMUND FLAHERTY; JONATHAN M.H. SHORT; JOSEPH A. BOYLE; MARK H. ANANIA; PETER HWICHAN NOH; SYMONE J. REDWINE; VINCENT P. RAO; WILLIAM J. HELLER
Firms Hogan Lovells US LLP; Kelley Drye Warren, LLP; McCarter & English, LLP; McCarter and English, LLP; Polsinelli PC
Link to Docket External link to docket
Small Molecule Drugs cited in TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC.
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up , ➤ Sign Up , and ➤ Sign Up .

Details for TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-04-05 1 lansoprazole of U.S. Patent No. 5,464,632 ("the '632 Patent"). …licensee of U.S. Patent No. 6,328,994 ("the '994 Patent") and U.S. Patent No. 7,431,942 (…#39;632 Patent. Ethypharm seeks relief in this action solely with respect to the '632 Patent. …#39;994 Patent, and Plaintiff Takeda LLC is the exclusive licensee. A copy of the '994 Patent is attached…#39;994 Patent, and Plaintiff Takeda LLC is the exclusive licensee. A copy of the '942 Patent is attached External link to document
2011-10-05 113 the “ ‘994 patent”), 7,431,942 the “ ‘942 patent”), and 5,464,632 (the “ ‘632 patent”). … three patents alleged to cover Takeda’s Prevacid SoluTab product (“SoluTab”): U.S. Patent Nos. 6,… I. The Technology and Patents-In-Suit The three patents at issue claim a pharmaceutical…to prevail in a patent infringement suit, a plaintiff must establish that the patent claim “covers …A[i]t is a bedrock principle of patent law that the claims of a patent define the invention to which External link to document
2011-10-19 116 Brief 1, 3 U.S. Patent No. 5,464,632 …disintegrating agent" in U.S. Patent No. 5,464,632, (Docket -No. 69-2, Ex. 3 to the Moriarty…phrases found in U.S. Patent No. 6,328,994 (the "994 patent") and U.S. Patent No. 7,431,942 (the…;994 patent, Col. 2, ln. 16 - 17; '942 patent, Col. 2 , ln. 19 - 20. 7 '994 patent, Col.… in the 5 '994 patent Col. 37, ln. 21 - 26; '942 patent Col. 37, in. 32- 36. External link to document
2011-11-07 117 terms in U.S. Patent No. 6,328,994 (the "'994 patent") and U.S. Patent No. 7,431,942 …claim construction ruling to the related patent U.S. Patent No. 7,875,292. …±10%). (Opinion at 8, 10; '994 patent, claim 2; '942 patent, claim 1.)2 In adopting Plaintiffs…7,431,942 (the "'942 patent")1. Among other disputed terms, the Court construed "fine granules…µm or less" from Claim 1 of the '994 patent to mean "fine granules up to and including External link to document
2012-01-25 130 Order on Motion for Reconsideration U.S. Patent No. 6,328,994 (the “‘994 patent”) and U.S. Patent No. 7,431,942 (the “‘942 patent”). The…particle diameter of 400 μm or less” in the ‘994 patent to mean “fine granules up to and including the …particle diameter of ... 300 to 400 μm” in the ‘994 patent and ‘942 to mean “average particle diameter of …2010 16 October 2014 3:10-cv-01723 830 Patent None District Court, D. New Jersey External link to document
2012-01-27 132 Letter ®. Three of the patents-in- NEW YORK suit, U.S. Patent Nos. 6,328,994 ("the '…#39;994 Patent"), 7,431,942 ("the '942 Patent"), and 7,875,292… patents"). NEWARK Pursuant to Local Patent Rules 3.3… assertion of patent infringement shall provide to each party asserting patent infringement …on prior art against Takeda patents run afoul of the Local Patent Rules. Plaintiffs were " External link to document
2012-05-02 180 Redacted Document .S. Patent Nos. 6,328,994 (the "'994 patent"), 7,431,942 (the "'942 patent), 7,…Takeda Patents-in-Suit Incorporate a Particle Size Requirement for Granules The Takeda patents-in-suit… '942 and '292 patent claims are similar to that of the '994 patent, except that the "…considerations as the '994 patent, this Court construed the '942 patent as also incorporating a measurement… ’994 and '942 patents would control claim construction of the '292 patent. (D.l. 97). ’:=’ External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Moodys
Julphar
Cipla
Healthtrust
Queensland Health
UBS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.